Efficacy and safety of sacubitril valsartan in treating heart failure with midrange ejection fraction after acute myocardial infarction in diabetic patients

Objective to evaluate the clinical efficacy and safety of sacubitril valsartan in the treatment of heart failure (HF) with midrange ejection fraction after acute myocardial infarction (AMI) in diabetic patients. From January 2015 to July 2020, HF patients with diabetes mellitus complicated with AMI...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Fanhao, Li, Hebo, Chen, Xiaoshu, Wang, Yi, Lin, Wei, Chen, Hao, Huang, Shiwei, Han, Sisi, Guan, Fanlu, Huang, Zhouqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812610/
https://www.ncbi.nlm.nih.gov/pubmed/35119021
http://dx.doi.org/10.1097/MD.0000000000028729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812610/
https://www.ncbi.nlm.nih.gov/pubmed/35119021
http://dx.doi.org/10.1097/MD.0000000000028729

Ejemplares similares